Alla Nyheter iCellate förklarar Fallstudier Skrivet om iCellate Event Forskning GeneMate NyheterElthera-led consortium initiates development of novel cancer diagnostics and therapeutics 24-11-2020 Elthera AG, iCellate Medical AB, Targos GmbH and Prof. Dr. Susanne Sebens at the Institute of Experimental Cancer Research (IET) at the University of…NyheteriCellate Medical tillför 26 MSEK via nyemission 19-11-2020 Stockholm, Sverige - 19 november 2020 - iCellate Medical har i dagarna avslutat en framgångsrik nyemission. Kapitalanskaffningen tillför bolaget drygt…GeneMateiCellates kliniska team 09-10-2020 En viktig komponent för långsiktig framgång ligger i ett starkt kliniskt teamGeneMateiCellate lanserar tjänsten GeneMate® inom ärftlig cancerrisk 30-09-2020 NyheteriCellate has been voted an organizational member of NACG 02-06-2020 iCellate is pleased to announce that we has been voted an organizational member of NACG, the Nordic Alliance for Clinical Genomics.NyheteriCellate is disrupting cancer care. Join us! 26-03-2020 We now recruit for 3 new positions!NyheteriCellate and Elthera consortium awarded with Eurostars grant of 25 MSEK for companion diagnostic development 13-03-2020 NyheteriCellate has been selected by Novartis to participate in their Techcare program 09-01-2020 NyheteriCellate hires - 3 new positions! 22-11-2019 Come and join the iCellate team!NyheteriCellate välkomnar sin nya R&D-chef Åsa Rosenquist 22-11-2019 NyheterBrinner du för laboratoriearbete i allmänhet och mikroskopering i synnerhet? 18-10-2019 Vi erbjuder en spännande arbetsmiljö i ett växande bolag där vi hoppas att du vill vara med och göra skillnad, inte bara hos oss utan även i…NyheterStockholmsbolag redo att revolutionera cancervården 26-09-2019 I dag lanserar iCellate Medical en tjänst som ska hjälpa läkare att sätta in rätt behandling för diagnostiserade cancerpatienter. NyheteriCellate is hiring an R&D Director 30-04-2019 We are looking for a new R&D DirectorNyheterTwo new colleagues 03-10-2018 Welcome Bonoshree and Sofia!NyheteriCellate Medical raises 16 MSEK in new equity to demonstrate its clinical validity and utility 28-06-2018 NyheterNew board appointed at extraordinary general meeting 15-12-2017 NyheterBuilding for the future 15-06-2017 New lab and office space in HagalundNyheteriCellate signs contract for new facility 23-12-2016 NyheteriCellate Medical closes 15 million SEK second round of funding 19-10-2016 NyheterIsoPic gets CE-approval 17-10-2016 12 Next
